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Abstract. ARIA is a member of a family of polypep- 
tide growth and differentiation factors that also in- 
cludes glial growth factor (GGF), neu differentiation 
factor, and heregulin. ARIA mRNA is expressed in all 
cholinergic neurons of the central nervous systems of 
rats and chicks, including spinal cord motor neurons. In 
vitro, ARIA elevates the rate of acetylcholine receptor 
incorporation into the plasma membrane of primary 
cultures of chick myotubes. To study whether ARIA 
may regulate the synthesis of junctional synaptic acetyl- 
choline receptors in chick embryos, we have developed 
riboprobes and polyclonal antibody reagents that rec- 
ognize isoforms of ARIA that include an amino-termi- 
nal immunoglobulin C2 domain and examined the ex- 
pression and distribution of ARIA in motor neurons 
and at the neuromuscular junction. We detected signifi- 
cant ARIA mRNA expression in motor neurons as 
early as embryonic day 5, around the time that motor 
axons are making initial synaptic contacts with their 
target muscle ceils. In older embryos and postnatal ani- 
mals, we found ARIA protein concentrated in the syn- 
aptic cleft at neuromuscular junctions, consistent with 
transport down motor axons and release at nerve termi- 
nals. At high resolution using immunoelectron micros- 
copy, we detected ARIA immunoreactivity exclusively 
in the synaptic basal lamina in a pattern consistent with 
binding to synapse specific components on the presyn- 
aptic side of the basal lamina. These results support a 
role for ARIA as a trophic factor released by motor 
neuron terminals that may regulate the formation of 
mature neuromuscular synapses. 
W 
E have been studying certain trophic interactions 
between motor neurons and muscle cells at em- 
bryonic neuromuscular junctions (nmjs)  1 to un- 
derstand how synapse formation is regulated. The embry- 
onic  chick  was  used  in  these  studies,  as  this  system is 
accessible to experimental manipulation, the procedures 
for culturing nerve and muscle cells are well established 
and events in synapse development are well characterized. 
In the chick hind limb, advancing motor neuron growth 
cones first enter the unsegmented muscle masses at em- 
bryonic day 4-5 (E4-5)  (Bennett et al.,  1980; Tosney and 
Landmesser, 1985),  a  time when mononuclear myoblast 
cells are fusing to form myotubes (Bonner and Hauschka, 
1974). Elementary neuromuscular synapses have been de- 
tected  on  embryonic day 6,  by measurement  of nerve- 
evoked  muscle  activity (Landmesser  and  Morris,  1975) 
and of synaptic potentials (Landmesser, 1978) and the ac- 
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cumulation of acetylcholine receptors  (AChRs)  at  end- 
plates (Smith and Slater, 1983; Fallon and Gelfman, 1989). 
Further  specialization of the  nmj  continues throughout 
embryonic life and posthatching (E21) including the cap- 
ping  of nerve  terminals by nonmyelinating perisynaptic 
Schwann cells, the assembly of specific components into a 
thickened synaptic basal lamina beneath nerve terminals 
and capping Schwann cell, and the nerve-dependent re- 
duction of extrasynaptic AChR density (for recent review 
see Hall and Sanes, 1993). 
An essential event of synaptic specialization is the con- 
centration of acetylcholine (ACh)  receptors  on  nascent 
myotubes and on myoblasts, in the vicinity of ingrowing 
motor neuron growth cones. This effect has been observed 
in vitro in cocultures, where "hotspots" of ACh sensitivity 
were detected where motor neurons contacted myotubes 
(Frank and Fischbach, 1979). Medium conditioned by mo- 
tor neurons can also stimulate increased ACh receptor in- 
corporation into the surface of cultured myotubes (Corfas 
et al.,  1993). It is likely, therefore, that one or more neu- 
ron-derived trophic factors plays a  role  in forming and 
maintaining high concentrations of AChRs at nmjs. One 
such factor is agrin, a 210-kD protein that causes the ag- 
gregation of preexisting muscle  AChRs into clusters  in 
vitro. Agrin is transported down motor axons and released 
at nerve terminals in vivo and may stimulate the formation 
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nerve terminals (Reist et al., 1992; Fallon and Hall, 1994). 
Regulation of the rates of AChR synthesis and insertion 
into the plasma membrane is less well understood. These 
effects might be mediated by acetylcholine receptor induc- 
ing activity (ARIA), a 42-kD protein found in extracts of 
chick brain.  ARIA purified  from adult  chick brains:  (a) 
specifically increases the rate of insertion of newly synthe- 
sized  receptors  into  the  plasma  membrane  of  cultured 
myotubes  (Usdin  and  Fischbach,  1986;  Dubinsky  et  al., 
1989);  (b) causes the elevation of AChR c~ (2-16-fold) and 
e  (10-fold)  subunit  mRNA  levels in  vitro  (Harris  et  al., 
1988;  Martinou et al., 1991);  and (c) increases expression 
of myotube sodium channels that are also found concen- 
trated at nmjs (Corfas and Fischbach, 1993). 
We recently purified ARIA to homogeneity and cloned 
a  corresponding cDNA,  named clone  M2,  from an E19 
chick spinal cord library (Falls et al., 1993).  The cDNA se- 
quence suggests that ARIA is synthesized as an intrinsic 
membrane precursor protein with a single transmembrane 
segment  linking  an  NH2-terminal  extracellular  domain 
and a COOH-terminal cytoplasmic domain. The extracel- 
lular  region  contains  consensus  N-  and  O-glycosylation 
sites,  an  Ig C2-1ike  domain,  an EGF-like  domain  and  a 
dibasic  motif  adjacent  to  the  transmembrane  sequence 
that may mediate proteolytic release from the membrane 
surface. 
Sequence comparison reveals that ARIA is a member of 
a family of growth factors that includes glial growth factors 
(GGFs) that stimulate Schwann cell proliferation (Good- 
earl et al., 1993; Marchionni et al., 1993), and neu differen- 
tiation factor and heregulin that effect proliferation or dif- 
ferentiation in diverse mammary tumor cell lines (Holmes 
et al., 1992; Wen et al., 1992). Nucleic acid sequence com- 
parisons show that these cDNAs are derived from a single 
gene that may generate in excess of 15 isoforms through 
alternative  splicing (Marchionni  et  al.,  1993;  Wen  et al., 
1994).  A  common structural feature of isoforms active in 
the above assays is the presence of the EGF-like domain. 
Indeed, this domain alone gives rise to all of the observed 
bioactivities (Holmes et al., 1992;  Goodearl, A. D., D. L. 
Falls,  and  G. D. Fischbach, unpublished  results).  In situ 
hybridization  analysis  has  shown  high  levels  of  ARIA 
mRNA in all cholinergic neurons in the adult CNS, includ- 
ing motor neurons (Corfas et al., 1995).  It is also found in 
the cerebellum, in sensory ganglia and in nonneural tissues 
such as the heart. 
Given its biological properties, its predicted molecular 
structure and the high levels of expression in motor neu- 
rons, ARIA is an excellent candidate for trophic function. 
Further, we hypothesize that ARIA is expressed by motor 
neurons  at the  time that  synapses form and  that  ARIA 
protein is present at the neuromuscular junction to exert 
its trophic effects. In this study, we tested this hypothesis 
by examining the expression of ARIA mRNA in develop- 
ing motor neurons and determining the location of ARIA 
protein at embryonic nmjs using light microscopy. We also 
used immunoelectron microscopy to determine the precise 
location of ARIA at nerve terminals as several laborato- 
ries  have  reported  an  activity  associated  with  synaptic 
basal lamina that increases the rate of AChR synthesis in 
adult  muscle  (Burden  et al.,  1979;  Goldman et al.,  1991; 
Brenner et al., 1992; Jo and Burden,  1992). We observed 
that ARIA mRNAs are present in motor neurons at the 
earliest time that clusters of AChRs have been observed 
(E5)  and  continue  to be expressed throughout  develop- 
ment. In El8 embryos, ARIA protein is clearly evident at 
nmjs,  consistent  with  axonal  transport  and  release  by 
nerve terminals. ARIA was concentrated in the thickened 
basal lamina throughout the synaptic zone in a pattern re- 
flecting entrapment of secreted ARIA through specific in- 
teractions with basal lamina molecules. ARIA immunore- 
activity was not detected before El6. Rapid accumulation 
soon thereafter suggests an event, perhaps binding in the 
synaptic cleft, that plays a role in the maturation and main- 
tenance of nmjs. 
Materials and Methods 
In Situ Hybridization 
In situ hybridizations were performed as previously described (Falls et al., 
1993; Sassoon and Rosenthal, 1993).  Tissues were fixed by immersion in 
4%  paraformaldehyde in  PBS  overnight  at  4°C.  After fixation, tissues 
were slowly dehydrated and embedded in paraffin. Serial transverse sec- 
tions (9 ~m) were collected on gelatinized glass microscope slides. Hy- 
bridization with sense and antisense probes was carried out at 52°C for 18 h 
in 50% deionized formamide, 0.3 M sodium chloride, 20 mM Tris-HCl pH 
7.4, 5 mM EDTA, 10 mM NaPO4 (pH 8), 10% dextran sulfate, lx  Den- 
hardt's solution, 50 txg/ml total yeast RNA with 3.5 x  104 cpm/ix135S-labeled 
RNA probe under siliconized coverslips. After hybridizations, coverslips 
were floated off in 5x SSC, 10 mM dithiothreitol at 50°C, and washed in 
50% formamide, 2x SSC, 10 mM dithiothreitol at 65°C. Slides were then 
rinsed in washing buffer, treated with RNAse A  (20 Ixg/ml, Sigma Chem. 
Co., St. Louis, MO), and washed at 37°C for 15 min in 2x SSC and then 
for 15 min in 0.1x SSC. Sections were dehydrated rapidly, processed for 
autoradiography using NTB-2 Kodak emulsion, exposed for 1 or 2 wk at 
4°C, and examined using both light- and dark-field illumination (Darklite; 
MVI, Avon, MA) under a dissecting microscope (SMZ-U; Nikon, Japan). 
The templates for probe transcription used in this study corresponded to 
the 5'  82 bp or 337  bp of ARIA clone M2. Sense and antisense RNA 
probes, labeled with [35S]UTP  (>1,000 Ci/mmol; New England Nuclear, 
Boston, MA), were generated by runoff transcription of the restriction di- 
gested plasmid using T7 or SP6 RNA polymerase. Transcripts were de- 
graded to an average length of 110 bp using alkaline hydrolysis (Sassoon 
and Rosenthal, 1993). 
Preparation of  Anti-ARIA (HM22) Antiserum 
A 28-amino acid peptide was synthesized (peptide synthesizer 430A; Ap- 
plied Biosystems, Inc., Foster City, CA; Fmoc chemistry) using the NH2- 
terminal 27 residues predicted from the chick proARIA1 X12 cDNA se- 
quence (MWATSEGPLQYSLAPTQTDVNSSYSTV) with an additional 
COOH-terminal cysteine. A  saturated solution of this partially soluble 
peptide was conjugated with keyhole limpet hemocyanin (KLH) using the 
cross-linking reagent sulpho-MBS (Pierce Chem. Co., Rockford, IL) ac- 
cording to the manufacturers instructions. After desalting the sample by 
gel filtration on a PD-10 column (Bio-Rad Labs., Richmond, CA) and lyo- 
philization, two rabbits were inoculated with 100 txg of peptide/KLH con- 
jugate followed by monthly boosts of 50 Ixg (Cocalico Biologicals, Reams- 
town, PA). Weekly bleeds were screened by ELISA using peptide coated 
plates. Serum from the rabbit with the highest titer (HM22) was affinity 
purified over a peptide/ovalbumin/Sepharose affinity column in  10 mM 
Tris-HC1, pH 7.4. After extensive washing of the column in 0.5 M NaC1, 10 
mM Tris, pH 7.4, a 0.1 M Glycine, pH 2.5 step was used to elute fractions 
containing one-tenth volume 0.4% NAN3, 1.0 M Tris, pH 8.0. Titer and pu- 
rity of eluted fractions were  monitored by ELISA  and reducing SDS- 
PAGE  respectively.  High  titer  fractions  were  pooled,  aliquoted  and 
stored at 4°C. All experiments in this study were carried out with affinity- 
purified HM22 antiserum. 
Immunohistochemistry 
Anterior latissimus dorsi (ALD) muscles from embryonic chicks were im- 
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bration to 15%  and then 30%  sucrose solutions in PBS. 10-15-1~m  sec- 
tions,  prepared  from  frozen  OCT-embedded  tissues  on  a  cryostat  at 
-18°C, were thaw mounted on to Superfrost Plus slides (Fisher Scientific, 
Pittsburgh, PA). After being washed in PBS, the sections were permeabi- 
lized and blocked for 30~0 min in 0.4% Triton X-100, 10% normal goat 
serum (NGS),  0.1  M  sodium phosphate, 0.5 M  NaCI, pH 7.4.  Sections 
were incubated overnight at room temperature in primary antibodies di- 
luted in the same permeabilizing/blocking buffer. Sections were washed 
with  PBS  three  times followed  by  a  1-h incubation  in  fluorescein or 
rhodamine  conjugated  secondary  antibodies  diluted  in  3%NGS/PBS. 
When used, rhodamine-labeled c~-bungarotoxin, prepared  according to 
Ravdin and Axelrod (1977), was coincubated with the secondary antibod- 
ies at a dilution of 1:300. The sections were then washed three times with 
PBS and viewed under Citifluor (Ted Pella, Inc,, Irvine, CA) on a fluores- 
cence microscope (Microphot; Nikon Inc., Melville, NY) equipped with 
rhodamine and fluorescein optics. A third filter block (UV-1B, excitation 
365 nm, barrier filter 400 nm) was used to observe autofluorescence that 
was not from fluorescein or rhodamine probes. 
Electron Microscopy 
For HRP labeling, the ALD muscles of E18 chick embryos were exposed 
and then rapidly immersion fixed in situ using 4%  paraformaldehyde, 
0.5%  glutaraldehyde in 0.1 M  Hepes, pH 7.4.  After 30 rain, the ALDs 
were dissected under fixative and fixed for an additional 30 min. After a 
PBS wash, muscle pieces were embedded in 5% agar in PBS and 75-p~m 
vibratome sections were cut. These were blocked for 30-60 min in 10% 
NGS, 0.1 M  sodium phosphate, 0.5 M NaCl, pH 7.4.  Sections were incu- 
bated overnight in HM22 antibody diluted at 1:100 in blocking buffer. The 
primary antibody was omitted from some sections as a control. Sections 
were washed with PBS three times followed by a  1 h incubation with bi- 
otin-labeled goat anti-rabbit IgG in PBS. After a 10-rain wash in PBS, sec- 
tions were  incubated in HRP-conjugated biotin complexed with avidin 
(Vector Labs., Inc., Burlingame, CA) for 1 h  and washed once again in 
PBS for 10 min. The sections were then developed for 7 min in DAB per- 
oxidase  substrate solution (0.1%  diaminobenzidine tetrahydrochloride, 
0.02% hydrogen peroxide, 0.1 M  Tris-HC1, pH 7.4) and washed in PBS. 
Sections were subsequently postfixed in 2% osmium tetroxide, 1.5% po- 
tassium ferrocyanide for 1 h followed by en bloc staining in 1% uranyl ac- 
etate, 0.1  M  sodium maleate, pH 6.0.  They were then dehydrated in a 
graded series of ethanols and embedded in epon/araldite. Silver-gray sec- 
tions (65  nm) were cut on a  Reichert Ultracut S  and viewed in a  Jeol 
100CX electron microscope operated at 60 kV. 
For the preparation of ultrathin cryosections (Tokuyasu, 1986),  ALD 
muscles were immersion fixed in 8% paraformaldehyde, 1% glutaralde- 
hyde, 0.6% picric acid in 0.1 M cacodylate, pH 7.4, for I h. The ALD mus- 
cle was dissected, washed in PBS, and cut into small blocks. The tissue was 
cryoprotected in 2.3 M sucrose for a minimum of 2 h and then rapidly fro- 
zen in liquid nitrogen. 70-80-nm sections were cut on a Reichert Ultracut 
S  microtome  equipped  with  an FCS  freezing chamber.  Sections were 
picked up on carbon-formvar-coated 200 mesh grids. Labeling of cryosec- 
tions  was  performed  according  to  the  procedures  of  Slot  and  Geuze 
(1985). Briefly, sections were quenched in 0.02% glycine in PBS, pH 7.4, 
followed by 10 min in blocking solution (0.1% BSA in PBS). Grids were 
then incubated in primary antibody (HM22 diluted 1:100) for 35 rain. Af- 
ter  several  rinses  in  blocking  solution,  grids  were  incubated  in  gold- 
labeled protein A for 30 rain. Grids were again washed briefly in blocking 
buffer before several rinses in PBS for a total of 30 rain. Grids were then 
fixed in 2% glutaraldehyde followed by a minimum of five 2-min washes 
in distilled water. Sections were then stained in 2% neutral uranyl acetate 
for 10 min and then stained for another 10 min in 1.8% methyl cellulose, 
0.2% uranyl acetate. Grids were picked up in small wire loops, drained, 
and allowed to dry before viewing. For double labeling experiments, a 
mixture of HM22 and SV2 antibodies, both diluted at 1:100  in blocking 
buffer was used in the first incubation. Secondary antibody labeling was 
accomplished by mixing 10-rim gold-labeled goat anti-mouse IgG (diluted 
1:40) with 5-nm protein A  gold (diluted 1:60)  and incubating the sections 
in this mixture for 30 min. The remaining steps were as for the HM22 sin- 
gle labeling experiments. 
Antibodies 
The  anti-flag M2 monoclonal antibody  (1:300)  was  from International 
Biotechnologies.  The  anti-neurofilament  monoclonal  antibody  (clone 
NN18,1:10), HRP-labeled goat anti-rabbit IgG (1:2,000)  and HRP-labeled 
goat anti-mouse IgO (1:2,000)  were from Boehringer Mannheim Corp. 
(Indianapolis, IN). Biotin-labeled goat anti-rabbit IgG (1:200)  was from 
Vector Labs. Fluorescein-labeled goat anti-rabbit IgG (1:300)  and rhoda- 
mine-labeled  goat  anti-mouse  IgG  (1:300)  were  from  Cappel  Labs. 
(CochranviUe, PA). 10-nm gold-labeled goat anti-mouse IgG (1:40)  was 
from Amersham Corp. (Arlington Heights, IL). 5- and 10-nm protein A 
gold (1:60)  were from J. Slot (University Utrecht, Netherlands). SV2 hy- 
bridoma supernatant (1:100)  was kindly donated by Dr. K. Buckley (Har- 
vard Medical School). 
COS Cell Transfection and Western Blotting 
Two expression plasmids were prepared: p12.6, a control plasmid with the 
ARIA coding sequence in the antisense orientation (Falls et al., 1993) and 
EuFlagl, which encodes ARIA in the sense orientation with the following 
peptide  sequence fused  to  the  NH2  terminus, MGDYYKDDDDKG- 
PVCWNSGVLRG, containing the flag epitope between residues 3 and 10 
(Hopp  et  al.,  1988).  EuFlagl  was prepared by insertion of an oligonu- 
cleotide cassette into a BstX1 site in the polylinker of the proARIA1 ex- 
pression construct p12.7 (Falls et al., 1993).  COS-7 cells grown to 70% 
confluence in 100-mm tissue culture petri dishes were transfected with 10 
IJ-g of either EuFlagl or p12.6 plasmids using the DEAE-dextran chloro- 
quine method. After 48 h, all cells were harvested and pelleted by centri- 
fugation. The pellets were resuspended in SDS-PAGE sample buffer with 
reducing agents and boiled for 5 min before electrophoresis in an 11% 
SDS-polyacrylamide gel. The protein bands were then electrophoretically 
transferred to an Immobilon membrane (Millipore Corp., Bedford, MA) 
in an electroblot  apparatus (Bio-Rad) in 10 mM CAPS, 10%  methanol 
pill 1. Quantitative transfer was confirmed using prestained protein stan- 
dards (Bio-Rad) run in the polyacrylamide gel. The blots were blocked in 
5% nonfat dried milk (NFDM) in PBS overnight at 4°C. Replicate lanes in 
the same blot were incubated separately in three different primary anti- 
body  solutions  diluted  in  5%  NFDM/PBS  as  follows:  HM22  (1:100), 
HM22 (1:100)  +  0.1 mg/ml peptide and aflag mAb M2 (1:300).  After 2 h, 
each blot was washed four times for 5 min in PBS containing 0.1% Tween 
20. The blots were then incubated for 1 h in either HRP-conjugated goat 
anti-rabbit IgG (HM22 blots), or HRP-conjugated goat anti-mouse IgG 
(M2 blot) diluted 1:2000  in 0.1% Tween 20/PBS. After being washed as 
above, the blots were developed in Renaissance chemiluminescence re- 
agent (Dupont, Boston, MA) and exposed to autoradiography film. 
Peptide Blocking Experiments 
The peptide antigen was suspended at i  mg/ml in PBS and agitated for 30 
min to saturate the solution. Undissolved peptide was removed by centri- 
fugation. HM22 antibody was diluted 1:10 in this peptide solution and agi- 
tated for a further 30 min. This solution was then diluted 1:10 either with 
the permeabilizing/blocking buffer for immunohistochemistry  or with 5% 
NFDM/PBS for Western blot analysis. 
Results 
Expression of  ARIA mRNA in Spinal Cord 
In earlier studies, we demonstrated by Northern blotting 
that ARIA k12 mRNA was expressed in the spinal cord 
and, by in situ hybridization, that the message was present 
in the ventral spinal cord of E7 chicks (Falls et al., 1993) 
when rudimentary neuromuscular connections have been 
formed.  In this  study,  we  examined  whether  ARIA ex- 
pression was detectable earlier. Two antisense riboprobes 
were prepared, one 82-bp long and the other 337 bp long, 
which  were specific for the coding sequence  at the NH2 
terminus of the ARIA protein (20 and 105 amino acids, re- 
spectively, Fig. 1) plus a short 5' untranslated sequence. In 
situ hybridization analysis of E5 chick embryos with each 
probe  showed  that  ARIA k12  mRNA was present  and 
concentrated in the ventral horn of the sl~inal cord where 
motor neuron cell bodies reside  (Fig. 2, a  and b). There 
was also hybridization within cells of the dorsal root gan- 
glion and somites. These signals are above background but 
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Figure  1.  Schematic  representation  of  the  ARIA  protein  se- 
quence compared with the sequences of various probes employed 
in this study. 
less intense than in the spinal cord. At this age (E5), we 
also found high levels of ARIA mRNA in other regions of 
the nervous system and the heart (an extensive analysis of 
ARIA expression in the  CNS was reported by Corfas et 
al.,  1995).  Expression  in  the  ventral  spinal  cord  persists 
throughout  embryonic  development  and  the  amount  of 
ARIA specific mRNA is maintained at similar levels, as 
judged by autoradiographic exposure times. At the time of 
hatching,  individual  motor neuron  nuclei  may be identi- 
fied as expressing high levels of ARIA message (Fig. 2, c 
and d).  A  337-bp sense probe gave background levels of 
hybridization at all ages studied (data not shown). 
Characterization of Anti-ARIA Antiserum 
Our success in detecting ARIA mRNA in motor neurons 
with even quite short NH2-terminal probes encouraged us 
to develop antibodies specific for this region to study the 
distribution ARIA proteins that contain an NH2-terminal 
Ig  domain.  A  polyclonal  antiserum,  called  HM22,  was 
raised against a peptide representing the 27 NHe-terminal 
amino-acids  predicted  from the  k12  clone  of chick pro- 
ARIA1 (Fig. 1). The specificity of affinity purified HM22 
antiserum was tested by Western  blot  analysis of ARIA 
expressed in COS cells. HM22 recognizes a major band at 
a MW of ~80-kD in extracts of COS cells transfected with 
ARIA (Fig. 3, lane 2) that is absent in control preparations 
of COS  cells  transfected  with  a  control  plasmid  (Fig.  3, 
lane 1).  The size of this band is consistent with the  626- 
amino acid ARIA construct used  (k12 plus epitope tag), 
taking into account glycosylation (Falls et al.,  1993)  and is 
comparable to the 85-kD band detected with a rat-specific 
anti-ARIA antibody after COS cells were transfected with 
the equivalent rat ARIA construct (Sandrock et al., 1995). 
The binding of HM22 was completely blocked by preincu- 
bation with  the  cognate peptide  antigen  (Fig.  3,  lane  4). 
The ARIA construct  included  a  "flag" epitope tag posi- 
tioned at the amino terminus. Western blots probed with 
M2, a flag sequence-specific antibody, confirmed that the 
80-kD protein was encoded by the transfected ARIA con- 
struct (Fig. 3, lane 6) and thus confirmed that HM22 rec- 
ognizes ARIA. A  second less abundant ARIA species of 
high  molecular  mass  was  specifically  labeled  with  both 
HM22 and M2 antibodies, although its precise identity re- 
mains unknown. Western blot analysis of El9 chick ALD 
Figure 2.  ARIA mRNA is expressed in early (E5) and late (E21) embryonic chick motor neurons. Sections of E5 (a and b) embryo and 
E21 (c and d) spinal cord were incubated with either 82 (a and c) or 337 bp (b and d) RNA antisense probes specific for the NH2 termi- 
nus of ARIA. Elevated ARIA expression in the E5 ventral spinal cord (arrows)  coinciding with newly differentiated  motor neurons is 
evident with both probes (a and b). By E21, individual highly expressing motor neuron nuclei (arrows)  may clearly be identified  (c and 
d). Bar: (a and b) 300 tzm; (c and d) 500 txm. 
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antibodies  to COS cell-expressed  flag epitope-tagged ARIA de- 
tected by immunoblot. Extracts of COS cells, transfected either 
with the p12.6 antisense control vector (lanes 1, 3, and 5) or a vec- 
tor  including  sequence  encoding  ARIA  tagged  with  the  flag 
epitope (Euflagl), were run on SDS-PAGE and electroblotted to 
PVDF membrane (lanes 2, 4, and 6). Membranes were incubated 
with HM22 anti-ARIA antibody in the absence (lanes 1 and 2) or 
presence (lanes 3 and 4) of peptide antigen. As a positive control, 
transfected ARIA protein was identified  using the M2 anti-flag 
monoclonal antibody (lanes 5 and 6). HM22 and M2 antibodies 
specifically  recognize  the  80-kD  species  predicted  from  the 
cDNA sequence (lanes 2 and 6). Both antibodies also detect a high 
molecular mass ARIA species that barely enters the polyacryla- 
mide gel and probably represents a covalent ARIA aggregate. 
muscle showed labeling of several protein bands (data not 
shown). However, only one HM22 positive band (MW = 
45 kD) was absent when the HM22 antibody was preincu- 
bated with peptide  antigen,  a  size consistent  with brain- 
purified ARIA (Falls et al., 1993). 
ARIA Protein Expression at the Chick nmj 
We established fixation conditions  using COS/CHO cells 
transfected with the flag-tagged ARIA construct (see Ma- 
terials  and  Methods),  and  subsequently  applied  them  to 
localize  ARIA  in  late  embryonic  chick  muscle.  We  se- 
lected the ALD muscle because its fibers are multiply in- 
nervated  and the  large number of regularly spaced nmjs 
allowed  us  to  examine  many endplates  in  each  section. 
The  staining  pattern  of  affinity-purified  HM22  on  E18 
chick ALD  muscle, illuminated  by indirect  immunofluo- 
rescence, reveals intense  arcs  of HM22 staining  that  are 
characteristic of chick nmjs at this  stage of development 
(Fig.  4  a).  This  was  confirmed  by  double  staining  with 
rhodamine-conjugated a-bungaroxin (Fig. 4 b), which irre- 
versibly binds to the clustered ACh receptors at nmjs. All 
ct-bungarotoxin sites were HM22 positive. The specificity 
of the HM22 binding pattern was confirmed by preincuba- 
tion of this antibody with peptide antigen. The staining at 
the nmj quantitatively disappeared in the presence of the 
peptide (Fig. 4, c and d). Therefore ARIA is present at all 
synapses examined in  the  ALD.  In addition,  ARIA-like 
immunoreactivity was found in every other muscle exam- 
ined including the fast posterior latissimus dorsi and pec- 
toralis muscles. 
To maximize the chance of observing extended lengths 
of preterminal axons immediately proximal to nmjs, we la- 
beled longitudinal sections of ALD muscles (Fig. 5 a). In 
this orientation,  the nmjs form a  line  beneath the  motor 
nerve, which  lies across the  muscle fiber (Fig.  5  b).  The 
size and shape of the ARIA staining pattern, revealed by 
HM22,  corresponds  well  with  that  of  tx-bungarotoxin- 
labeled AChRs  seen en face in  this  orientation.  In con- 
trast, ARIA protein could not be detected along the axon: 
the HM22 staining pattern (Fig. 5 a) was not coextensive 
with that of the  160-kD neurofilament protein (Fig. 5 b). 
Also, we were unable to detect ARIA-like immunoreac- 
tivity with HM22 in motor neuron cell bodies in transverse 
sections of the lumbar and cervical spinal cord (data not 
shown). We cannot exclude the possibility that Ig-contain- 
ing ARIA isoforms are present at very low levels in these 
regions  of  motor  neurons.  However,  the  finding  that 
ARIA protein accumulates only at the endplate supports 
the hypothesis that ARIA is involved in the development 
and maintenance of the synapse in vivo. 
Developmental Expression of  ARIA 
The  expression  of ARIA at ALD  muscle endplates  was 
examined during development on embryonic days E5, 8, 
10, 12, 14 (data not shown), 15, 16, and 17 (Fig. 6). Despite 
numerous attempts using a range of fixation and staining 
conditions, we did not observe ARIA-like immunoreactiv- 
ity at nmjs on or before E15, when patches of AChRs are 
clearly  present  (Fig.  6,  a  and  b)  and  functional  chick 
nerve-muscle synapses have been detected in ALD mus- 
cles (Bennett and Pettigrew,  1974).  One day later (E16), 
all nmjs are labeled (Fig. 6 c), although apparently less in- 
tensely than at El7 (Fig. 6 e) and later stages. These obser- 
vations do not eliminate the possibility that there may be 
low levels of functional ARIA present at or before El5. 
However,  the  dramatic and  apparently  synchronous  ap- 
pearance  of ARIA-like  immunoreactivity in  many hun- 
dreds  of endplates  suggests  that  it  is  a  tightly regulated 
process and probably reflects a rapid increase in the syn- 
aptic ARIA concentration. 
ARIA Is Concentrated in the Synaptic Cleft 
To define the location of ARIA at the nmj more precisely, 
ALD  endplates were studied  at the  electron microscope 
level. Vibratome sections were incubated with HM22 anti- 
bodies and developed using the HRP-ABC method (Hsu 
et  al.,  1981).  After  osmication  and  embedding  in  epon/ 
araldite,  grazing 65-nm sections were  cut  across the  sur- 
face of the vibratome sections. The insoluble HRP reac- 
tion product filled the synaptic cleft at every nmj identified 
(Fig. 7 a, between arrows). The stain filled the cleft evenly 
and  was  present  throughout  the  thickened  basal  lamina 
characteristic of the synaptic zone, including  the perisyn- 
aptic Schwann cell/muscle interface at the margins of the 
synaptic cleft. In some sections, the perisynaptic Schwann 
cell capping the nerve terminal extended a significant dis- 
tance on either side along the muscle surface (Fig. 7 b). In- 
Goodearl et al. ARIA Localization at Embryonic Neuromuscular Junctions  1427 Figure 4.  Immunohistological detection of ARIA immunoreactivity at El8 embryonic neuromuscular junctions. Transverse sections of 
El8 ALD muscle were double labeled with rhodamine-conjugated a-bungarotoxin and HM22 anti-ARIA antibody labeled with fluo- 
rescein-conjugated goat anti-rabbit IgG secondary antibodies and illuminated either with fluorescein (a and c) or rhodamine (b and d) 
optics. The section illustrated in the lower panels was incubated with HM22 that had been preincubated with an excess of peptide anti- 
gen. The small number of features apparent after peptide blocking of HM22 staining in c represent nonspecific autofluorescence from 
erythrocytes. Bar, 30 ~m. 
tense ARIA immunoreactivity was continuous in the cleft 
beneath both Schwann cell and nerve terminal but did not 
extend beyond the synaptic zone defined by the end of the 
Schwann cell processes.  In occasional sections, low levels 
of staining on the muscle basal lamina a short distance be- 
yond the Schwann cell were apparent. 
Since the sections for electron microscopy were cut from 
the surface of vibratome sections, the cytoplasm was freely 
accessible to all antibodies  and staining reagents. Despite 
this exposure, no intracellular staining was evident in mus- 
cle, nerve  or Schwann cells  (Fig.  7, a  and b).  Subcellular 
organelles  and vesicles were also unstained,  but since de- 
tergent  that  would  have  permeabilized  these  structures 
was not used, we are unable to conclude that ARIA was 
absent from them. 
The  HM22  epitope  is  present  in  the  extracellular  do- 
main of the membrane bound proARIA precursor protein 
as well as in soluble ARIA released from motor neurons. 
It is unlikely that ARIA is associated solely with the pre- 
synaptic  nerve  cell  plasma  membrane,  as  the  synaptic 
ARIA staining  includes  extensive  regions where  there  is 
no direct apposition between vesicle-filled nerve terminals 
and  the  basal  lamina  on  the  muscle  surface  (Fig.  7  b). 
ARIA  staining  was  absent  from the  extra-synaptic  basal 
lamina  of  muscle  and  the  nonsynaptic  basal  lamina  of 
Schwann cells (Fig. 7, a  and b). No axonal ARIA labeling 
was apparent intracellularly or on the axolemma (Fig. 7 a). 
Thus even at high resolution, ARIA-like immunoreactiv- 
ity appears restricted to the synaptic basal lamina. 
Further  evidence  for ARIA  association  with  the  basal 
lamina at the electron microscope level was obtained using 
immunogold labeling methods. In this technique, ultrathin 
cryosections were labeled  with HM22  and colloidal gold- 
labeled protein A. We identified nmjs by a combination of 
criteria  including  the:  (a)  increased  density  beneath  the 
sarcolemma,  (b)  thickened  basal  lamina,  (c)  presence  of 
synaptic vesicle profiles, and (d) electron dense cytoplasm 
of perisynaptic  Schwann cell processes.  The gold-labeled 
protein A  formed a dense layer in the synaptic basal lam- 
ina of muscle cells  at many endplates  identified  by these 
criteria,  confirming the  observation that  this  region con- 
tains  highly concentrated  ARIA  (Fig.  8  a).  As  was seen 
with the HRP labeling technique, no ARIA immunoreac- 
tivity  was  apparent  in  extra-synaptic  regions  of  muscle 
basal  lamina  (Fig.  8  a,  open arrow). In contrast with  the 
HRP stain,  which uniformly filled  the  cleft,  the colloidal 
gold label was not evenly distributed across the basal lam- 
ina. Rather, it is largely confined to the surface of the elec- 
tron dense layer of the lamina on the presynaptic side (Fig. 
8 b). The labeling extends for the length of the thickened 
basal  lamina  including  areas  of  Schwann  cell-myotube 
contact where  no nerve terminals  are  apparent  (Fig.  8 a, 
arrowhead). This clearly demonstrates that ARIA is local- 
ized within the basal lamina, although it does not exclude 
"/'be Journal of  Cell Biology,  Volume 130, 1995  1428 Figure 5.  ARIA immunoreactivity is not detectable in motor ax- 
ons identified with anti neurofilament  antibodies.  Longitudinal 
sections of El8  ALD muscle were double labeled  with HM22 
anti-ARIA antibodies  and  monoclonal  antibodies  specific  for 
160-kD  neurofilament  protein  followed by  fluorescein-labeled 
goat anti-rabbit and rhodamine-labeled goat anti-mouse second- 
ary  antibodies  and  illuminated  with  fluorescein  optics  (a)  or 
rhodamine  (b)  optics.  A  succession of HM22  immunoreactive 
nmjs are seen en face (a, arrows) along the path of neurofilament 
labeled motor axons (b) that appear to be HM22 negative (a). 
Bar, 30 txm. 
the possibility that it may also be associated with the pre- 
synaptic nerve terminal plasma membrane.  However, the 
relative  uniformity of labeling  along the  entire  length  of 
the cleft argues  against concentration in the nerve termi- 
nal membrane. Also, we did not detect any labeling associ- 
ated with presynaptic plasma membrane that had become 
separated  from the  basal  lamina  during  sample  prepara- 
tion. In different sections, a range of immunogold labeling 
densities  were  seen,  including  a  few junctions  where  we 
could not be convinced of above background labeling. We 
do not yet know if this represents  heterogeneity between 
synapses  or reflects  the  variability  inherent  in  this  tech- 
nique. 
An added benefit of colloidal gold labeling was that an- 
tibody incubations were carried out directly on 70-80-nm 
cryosections, allowing the reagents access to all intracellu- 
lar compartments. Although nerve terminals were incom- 
pletely preserved,  many presynaptic vesicle profiles were 
positively identified (Fig. 8 b, curved arrows) and in other 
sections we were able to detect significant concentrations 
of a  synaptic vesicle  antigen  (SV2)  associated  with these 
structures  (data  not  shown).  These  vesicles  were  not la- 
beled  with  HM22-associated  gold particles  (Fig.  8  b).  In 
occasional sections, we have seen a few such gold particles 
at  synaptic vesicles  but  at  densities  close  to background 
and at levels far less than SV2 labeling. This result, in con- 
trast to that obtained with the HRP method, allows us to 
conclude that  if ARIA  is present  in synaptic vesicles, its 
concentration  is  relatively  low.  Physiologically,  this  may 
reflect the use of an alternate mode of ARIA secretion at 
Figure 6.  Comparison of HM22 labeling at nmjs at  embryonic 
days 15 (a and b), 16 (c and d), and 17 (e and f). Transverse sec- 
tions of ALD muscle were double labeled with rhodamine-conju- 
gated  c~-bungarotoxin  and  HM22  anti-ARIA antibody labeled 
with fluorescein-conjugated goat anti-rabbit IgG secondary anti- 
bodies  and  illuminated  either  with fluorescein  (a,  c,  and  e)  or 
rhodamine (b, d, and f) optics. ARIA immunoreactivity is not de- 
tectable at E15 (a) but is clearly present at all a-bungarotoxin la- 
beled nmjs on E16 and El7 (c and e). Bar, 30 0.m. 
the nerve terminal.  In summary, our immunoelectron mi- 
croscopy study demonstrates  that  Ig containing ARIA is 
concentrated  in  the  synaptic  basal  lamina  of embryonic 
chick neuromuscular junctions. 
Discussion 
In this study, we used riboprobes and polyclonal antibod- 
ies specific for the isoforms of ARIA that contain  an Ig 
domain to characterize their expression and distribution in 
motor neurons and at motor endplates  in chick embryos. 
We found that ARIA mRNA is present in motor neurons 
at the earliest stages of synaptogenesis and that high levels 
of  expression  are  then  seen  throughout  embryogenesis. 
Further,  ARIA-like  immunoreactivity  was  found  to  be 
concentrated  in  the  basal  lamina  of  the  synaptic  cleft. 
These  observations  are  consistent  with  the  model  that 
ARIA is synthesized and secreted by motor neurons. Al- 
though we were not able to confirm that ARIA is present 
within the nerve terminals,  several lines of evidence indi- 
cate  that  the  ARIA  protein  within  the  synaptic  cleft  is 
nerve derived. First, there is strong ARIA mRNA expres- 
sion in motor neurons. Our in situ hybridization studies in 
the chick have detected  ARIA mRNA  in all motor neu- 
rons from E5  onwards throughout  embryogenesis. These 
studies failed to detect significant hybridization in muscle 
tissue, another possible source of ARIA in the cleft. Com- 
parative studies that assessed ARIA mRNA expression by 
Northern blot analysis have also demonstrated significant 
levels of ARIA mRNA in spinal cord and brain but again 
not in muscle (Holmes et al., 1992; Wen et al., 1992, 1994). 
Goodearl et al. ARIA Localization at Embryonic Neuromuscular  Junctions  1429 Figure 7.  Transmission electron micrographs of El8 chick ALD neuromuscular junctions labeled with HM22 anti-ARIA antibodies. (a) 
The ARIA/HM22 complex was illuminated using the HRP-ABC stain with DAB as a substrate. The resulting dark precipitate was seen 
only in the synaptic cleft, indicated by the arrows. The nonsynaptic basal laminae (BL) of muscle and Schwann cells were unstained. No 
cytoplasmic staining was evident within the nerve axon (Ax), nerve terminal (Te),  Schwann cell (Sc) or muscle (M).  (b) A  section at 
higher magnification, immunolabeled as above, showing extensive ARIA staining between the perisynaptic Schwann cell and muscle 
surface in addition to that seen immediately beneath the nerve terminal. The absence of stain in the nonsynaptic basal lamina of the 
Schwann cell and an adjacent muscle cell is particularly evident in this section. Bars: (a) 0.5 txm; (b) 0.25 ~m. 
The Journal of Cell Biology, Volume 130, 1995  1430 Figure 8.  Immunogold staining with HM22 anti-ARIA antibodies on ultrathin cryosections of E18 chick ALD muscle. (a) The ARIA/ 
HM22 complex is labeled by protein A-conjugated 10-nm colloidal gold particles that are present at high density throughout the synap- 
tic cleft (between filled arrows). The arrowhead indicates a labeled region between a perisynaptic Schwann cell and the muscle surface. 
The open arrow indicates a region of unlabeled muscle basal lamina. (b) A  detail of a is further magnified to show that the gold label is 
almost exclusively restricted to the outer surface of the basal lamina (BL). Curved arrows show examples of synaptic vesicles within the 
nerve terminal that are unlabeled. Schwann cell (Sc), nerve terminal (Te), and muscle cell (M) are indicated. Bars: (a) 0.2 Ixm; (b) 0.1 ixm. 
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has been obtained from assays of ARIA activity in cell cul- 
ture. When myotubes were cultured in the presence of me- 
dium conditioned by purified embryonic chick motor neu- 
rons, the rate of AChR incorporation increased and p185, 
the putative ARIA receptor (Corfas et al., 1993;  Falls et 
al., 1993), was rapidly and specifically phosphorylated on 
tyrosine  residues.  In  contrast,  no  such  activity  was  de- 
tected in medium conditioned  by embryonic muscle cell 
cultures.  Third,  we  have  observed an  acute  decrease  in 
ARIA-like immunoreactivity at adult rat nmjs within 2 d 
of denervation (Sandrock et al., 1995).  The Schwann cell 
capping the nerve cell is another potential source of ARIA 
protein in the synaptic cleft, although no significant in situ 
hybridization with either riboprobe used in this study was 
observed in muscle. In summary, the weight of evidence 
suggests that ARIA protein at the nmj is nerve derived, al- 
though the possibility that muscle or Schwann cells are a 
source of ARIA cannot be fully excluded. 
The  absence  of significant ARIA immunoreactivity in 
spinal cord motor neuron cell bodies, compared with the 
high  level of mRNA expression,  suggests that  the  com- 
bined rates of transport and degradation of ARIA protein 
are equal to or greater than the rate of ARIA protein syn- 
thesis, leading to little accumulation of ARIA within the 
cell soma. From the high levels of ARIA protein that we 
observe at motor nerve terminals, we conclude  that  na- 
scent  ARIA  is  rapidly  transported  from  the  cell  body 
down the axon and released at the end plate. Precedent for 
this phenomenon has been set by other motor neuron pro- 
teins,  including  the  synaptic vesicle protein  SV2  that  is 
present  at high  concentrations  in motor nerve terminals 
but is undetectable in motor neuron cell bodies (Buckley 
and  Kelly,  1985).  Direct  evidence  that  ARIA  is  trans- 
ported away from the motor neuron cell body has also re- 
cently  been  obtained:  ARIA-like  immunoreactivity  ap- 
pears in proximal motor axons when  axonal transport is 
blocked by colchicine  (Sandrock  et al.,  1995).  Rapid ax- 
onal transport would  be consistent with  our observation 
that ARIA protein is highly concentrated at the nerve ter- 
minal. Furthermore, localization of ARIA to the nmj ful- 
fills a key prerequisite of its proposed role as atrophic fac- 
tor that acts on muscle. 
We have observed high levels of ARIA-like immunore- 
activity  in  the  synaptic  cleft  using  electron  microscopy 
with  both  HRP  and  immunogold  labeling  techniques. 
However,  we  were  unable  to  detect  significant  levels 
within the nerve terminals either in vesicles or in the cyto- 
plasm. If ARIA were free to diffuse after release, its extra- 
cellular concentration would be at or below that within the 
nerve.  The intense  labeling that we observe is therefore 
evidence that ARIA becomes trapped within the synaptic 
cleft. This entrapment is unlikely to be a nonspecific phys- 
ical effect, as proteins much larger than ARIA, such as fer- 
ritin whose molecular mass is more than 10 times greater 
than that of ARIA, rapidly diffuse within the synaptic cleft 
(Oldfors  and  Fardeau,  1983).  Thus  the  concentration  of 
ARIA within the cleft is likely to be due to specific molec- 
ular interactions. 
ARIA immunoreactivity was detected between the mus- 
cle and perisynaptic Schwann cell as well as immediately 
beneath nerve terminals. The fact that ARIA immunore- 
activity was restricted to the basal lamina of the synaptic 
zone and that it was found almost exclusively on the pre- 
synaptic part of the lamina would support the hypothesis 
that the distribution of ARIA is determined by the distri- 
bution  of one  or more components  of the  basal  lamina 
with which it interacts. If so, it follows that the appearance 
of the intense ARIA-like immunoreactivity in the synaptic 
cleft between E15 and E16 may be determined by the ac- 
cumulation of the ARIA-binding molecules. Lower but bi- 
ologically active concentrations of ARIA may be present 
at the synapse earlier, when AChR clusters are first ob- 
served. This view is supported further by in vitro studies 
where ARIA activity was detected in medium conditioned 
by chick motor neurons as early as E8 (data not shown). 
Whether secretion arises as soon as ARIA mRNA is de- 
tected at E5 has yet to be determined. 
One class of molecules that may mediate the association 
of ARIA with  the  synaptic cleft is heparan  sulfate pro- 
teoglycans (HSPGs). ARIA is known to interact with hep- 
arin in vitro, an affinity that was exploited in several strat- 
egies used to purify ARIA family ligands (Holmes et al., 
1992; Peles et al., 1992; Falls et al., 1993). Low doses of hep- 
arin inhibit the ARIA-dependent autophosphorylation of 
the p185 ARIA receptor (Loeb and Fischbach, 1995).  This 
effect was not observed with the EGF domain alone, sug- 
gesting that  the  interaction  with  heparin is mediated  by 
the Ig C2 domain that includes two regions of primary se- 
quence rich in basic residues. Although a HSPG is heavily 
concentrated  at the nmj (Sanes et al.,  1986), the sulfated 
glycosaminoglycan chains are thought to be located mainly 
in the lamina rara (Kanwar and Farquhar, 1979), an elec- 
tron  lucent  layer  immediately  proximal  to  the  muscle 
plasma membrane. If HSPGs bind ARIA in vivo, this dis- 
tribution  becomes difficult to reconcile with the  concen- 
tration of ARIA labeling observed on the presynaptic side 
of the basal lamina. There are a number of candidates in 
addition to HSPGs that may mediate ARIA binding to the 
synaptic  basal  lamina.  Ig  C2  domains  are  contained  in 
many extracellular matrix molecules and have been shown 
to mediate both homophilic and heterophilic protein/pro- 
tein interactions  (Williams and Barclay,  1988)  and some 
such proteins, including NCAM for example (Sanes et al., 
1986),  are specifically concentrated  in the  synaptic basal 
lamina. Direct measurement of ARIA-binding affinities of 
such  candidate  proteins  coupled  to  further  electron  mi- 
croscopy studies on their distribution in the synaptic basal 
lamina promise to define ARIA's molecular-binding part- 
ners in the synaptic cleft. 
ARIA is synthesized as a precursor with a single trans- 
membrane region  dividing cytoplasmic and  extracellular 
domains.  The  extracellular  domain  is  released  through 
proteolytic cleavage and may be processed further (Loeb 
and Fischbach,  1995).  These different forms occupy dis- 
crete extracellular compartments, and may perform differ- 
ent functions according to their distinct distribution.  The 
dramatic appearance of ARIA-like immunoreactivity be- 
tween E15 and E16 and the persistence of this staining un- 
til hatching and into adulthood suggests that basal lamina- 
associated ARIA is likely to be involved in the maturation 
and  maintenance  of synapses.  During  the  latter  part  of 
gestation,  the  number of AChRs  on the  muscle  surface 
drops  dramatically  while  receptors  beneath  the  motor 
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synaptic density is as much as  10,000  times greater than 
that found extrasynaptically (Fertuck and Salpeter, 1976). 
Release of ARIA from the synaptic basal lamina, either by 
dissociation  or proteolysis  (Loeb  and  Fischbach,  1995), 
might be necessary to effect AChR synthesis at the level 
required to maintain this extreme density. 
The concentration of ARIA  within the  cleft between 
El5 and E16 may be important for the regulation of syn- 
aptic molecules other than AChRs.  For example, ARIA 
has been shown to increase the number of sodium chan- 
nels on the surface of cultured muscle cells (Corfas and 
Fischbach, 1993). In addition, the concentration of ARIA 
within the synaptic cleft could also effect changes in peri- 
synaptic Schwann cells that are present as early as E8 (At- 
sumi, 1977), particularly if, like axonal Schwann cells, they 
possess receptors for ARIA family ligands (Marchionni et 
al., 1993). 
Basal  lamina-associated  ARIA  may  also  function  in 
maintaining the integrity of synapses during tissue regen- 
eration after nerve injury. After nerve crush, motor neu- 
rons regrow down the path of the degenerating nerve and 
reinnervate their target muscle at the original synaptic site 
(Marshall et al., 1977). Evidence has been presented that 
demonstrates that a nerve-derived basal lamina constitu- 
ent (or constituents) maintains synapse-specific AChR ex- 
pression in the muscle at the site of the original nmj during 
nerve regeneration (Burden et al.,  1979; Goldman et al., 
1991;  Brenner et al.,  1992;  Jo and Burden,  1992). Basal 
lamina-associated ARIA is clearly a  strong candidate to 
regulate AChR expression in the absence of functional in- 
nervation. This hypothesis is strengthened by the observa- 
tion that reduced but significant levels of ARIA-like im- 
munoreactivity persist at nmjs after denervation (Jo et al., 
1995;  Sandrock et al., 1995). Confirmation of the role of 
ARIA  in  the  maintainance  and  repair  of  the  synapse 
awaits the development of reagents that are able to per- 
turb  ARIA's  function over extended periods  of time in 
vivo. 
This  study focused on members  of the  ARIA  ligand 
family that possess an NH2-terminal Ig C2 domain because 
these isoforms were the first to be purified and are abun- 
dantly represented in cDNA libraries prepared from di- 
verse sources (Marchionni et al.,  1993; Wen et al., 1994). 
However, there are two classes of alternative splice vari- 
ants  that we  did not detect: those that possess different 
NH2-terminal regions and thus no HM22 epitope. One is 
the "GGF2" class whose cDNAs encode a 245-amino acid 
domain of unknown function spliced at the NH2 terminus 
of the Ig C2 domain in place of the HM22 epitope (Mar- 
chionni et al., 1993). Although no "GGF2" sequences have 
been reported in the chick, using S1 nuclease protection 
we have identified a splice junction in embryonic chick spi- 
nal cord mRNA that is consistent with the presence of the 
GGF2 isoform (Rosen, K. M. and G. D. Fischbach, unpub- 
lished results). Secondly, cDNAs have been identified in 
embryonic spinal cord where, in place of the Ig domain, an 
entirely unrelated NH2-terminal domain is spliced to the 
EGF-like domain (Kuo, Y., X. Yang, and L. Role. 1994. 
Society for Neuroscience Annual Meeting. Abstract 452.18; 
Ho et al., 1995). Thus we have identified a subset of ARIA 
isoforms at the neuromuscular junction that extends ob- 
servations made  in parallel by other  groups who found 
ARIA-like  immunoreactivity at  adult  mammalian  nmjs 
using antibodies that did not distinguish between different 
members of the ARIA ligand family (Chu et al., 1995; Jo 
et al., 1995). 
As discussed above, it is likely that the Ig C2 domain 
plays a role in the interaction of ARIA with the synaptic 
basal lamina. This may represent a more general function 
of NH2-terminal domains acting as determinants of the ex- 
tracellular distribution of members  of this ligand family 
and thus for presenting the bioactive EGF-like domain to 
target cells. This hypothesis is consistent with a prelimi- 
nary report that GGF2 NH2-terminal domain-specific im- 
munoreactivity is present in adult rat motor axons but not 
at nerve terminals (Jo et al.,  1995). A  comparison of the 
distribution of these three classes of ARIA-like ligands in 
motor  neurons  at  different  embryonic  ages  would  be 
highly informative as to the role of the NH2-terminal do- 
mains in biological function of ARIA. 
In  this  study,  we  have  demonstrated  the  presence of 
ARIA  protein in  the  synaptic  cleft between nerve  and 
muscle. This is consistent with the hypothesis that ARIA 
has a trophic-signaling function between these cells. Fur- 
thermore we  have  shown  that  ARIA  is  highly  concen- 
trated in the synaptic basal lamina, probably as a result of 
specific binding to other proteins. The stage is now set for 
examination of ARIA's role in initial events of synapto- 
genesis and its possibly distinct role at mature synapses by 
blocking ARIA function in vitro and in vivo. 
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